What’s next after China court freezes US$318m in Nexperia assets amid Wingtech battle?
The Chinese courts’ freeze of 2.14 billion yuan (about 318 million US dollars) in Nexperia’s related assets indicates that its manufacturing base in China has become further detached from European headquarters in the ongoing dispute over long-term management. The Dongguan Intermediate People’s Court in Guangdong Province, where Nexperia’s largest assembly and testing facility is located, has frozen the equity of four subsidiaries. This move has isolated Nexperia’s local facilities in the ongoing legal confrontation, and the independence of its operations has been substantively confirmed.